SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (ALGS) (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results